Citation Tools
PDFLate-breaking abstracts
Biomarkers, immune monitoring, and novel technologies
760 Trough levels of ipilimumab in serum as a potential predictive biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 760 Trough levels of ipilimumab in serum as a potential predictive biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab